+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 20Years - 70Years
FEMALE
ID07846722

Comparing Esmolol and Dexmedetomidine Infusions to Reduce Opioid Use in Laparoscopic Gynecological Surgery A Randomized, Double-Blind Placebo-Controlled Trial

Led by Vasiliki Samartzi · Updated on 2026-09-29

90

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of continuous low-dose infusions of esmolol and dexmedetomidine compared to placebo on opioid use and pain relief in patients undergoing laparoscopic hysterectomy. The study aims to address postoperative pain management challenges and explore opioid-sparing strategies with these two drugs during anesthesia and after surgery. This is a randomized, double-blind, placebo-controlled trial with three groups designed to compare opioid consumption and quality of recovery. Participants receive a loading dose followed by a continuous infusion of either esmolol, dexmedetomidine, or placebo normal saline during surgery. The esmolol group receives a loading dose of 0.05 mLkg and a maintenance dose of 0.3 mLkgh, while the dexmedetomidine group receives a loading dose of 0.05 mLkg and a maintenance dose of 0.3 mLkgh. The placebo group receives equivalent volumes of normal saline. All infusions are administered intraoperatively over a 10-minute loading period followed by continuous maintenance. During the study, participants opioid use is monitored in the first 24 hours after surgery using patient-controlled analgesia PCA devices. Pain intensity, sedation levels, nausea, vomiting, and quality of recovery are assessed at various time points up to 24 hours postoperatively. Additional measures include intraoperative fentanyl and propofol consumption, heart rate and blood pressure monitoring, length of stay in the recovery unit, and total hospital stay. Safety and satisfaction from analgesia are also evaluated. Participants are involved in follow-ups during their hospital stay until discharge, approximately 4 days post-surgery.

CONDITIONS

Brief Title

Esmolol Versus Dexmedetomidine for Opioid-sparing in Laparoscopic Gynecological Surgery

Research Team

V

Vasiliki Samartzi

K

Kassiani Theodoraki, PhD, DESA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here